Notre Dame Intermédica Participações
Market Cap
R$59.8b
Last Updated
2021/01/21 22:00 UTC
Data Sources
Company Financials +
Executive Summary
Notre Dame Intermédica Participações S.A. More Details
Rewards
Risk Analysis
Snowflake Analysis
Solid track record with adequate balance sheet.
Share Price & News
How has Notre Dame Intermédica Participações's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: GNDI3 is more volatile than 90% of BR stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: GNDI3's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of BR stocks.
Market Performance
7 Day Return
6.5%
GNDI3
15.2%
BR Healthcare
-0.7%
BR Market
1 Year Return
38.1%
GNDI3
48.5%
BR Healthcare
0.8%
BR Market
Return vs Industry: GNDI3 underperformed the BR Healthcare industry which returned 48.5% over the past year.
Return vs Market: GNDI3 exceeded the BR Market which returned 0.8% over the past year.
Shareholder returns
| GNDI3 | Industry | Market | |
|---|---|---|---|
| 7 Day | 6.5% | 15.2% | -0.7% |
| 30 Day | 29.3% | 28.2% | 4.9% |
| 90 Day | 55.9% | 67.1% | 16.8% |
| 1 Year | 38.5%38.1% | 49.6%48.5% | 3.5%0.8% |
| 3 Year | n/a | 180.1%156.0% | 54.4%37.8% |
| 5 Year | n/a | 747.6%622.1% | 219.0%164.3% |
Long-Term Price Volatility Vs. Market
How volatile is Notre Dame Intermédica Participações's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall St
Is Notre Dame Intermédica Participações (BVMF:GNDI3) Using Too Much Debt?1 month ago | Simply Wall St
Notre Dame Intermédica Participações S.A.'s (BVMF:GNDI3) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?2 months ago | Simply Wall St
Will The ROCE Trend At Notre Dame Intermédica Participações (BVMF:GNDI3) Continue?Valuation
Is Notre Dame Intermédica Participações undervalued compared to its fair value and its price relative to the market?
83.2x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: GNDI3 (R$100.31) is trading above our estimate of fair value (R$34.61)
Significantly Below Fair Value: GNDI3 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: GNDI3 is poor value based on its PE Ratio (83.2x) compared to the BR Healthcare industry average (36.8x).
PE vs Market: GNDI3 is poor value based on its PE Ratio (83.2x) compared to the BR market (17.1x).
Price to Earnings Growth Ratio
PEG Ratio: GNDI3 is poor value based on its PEG Ratio (4.1x)
Price to Book Ratio
PB vs Industry: GNDI3 is overvalued based on its PB Ratio (8.6x) compared to the BR Healthcare industry average (5.8x).
Next Steps
Future Growth
How is Notre Dame Intermédica Participações forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?
20.2%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GNDI3's forecast earnings growth (20.2% per year) is above the savings rate (9.9%).
Earnings vs Market: GNDI3's earnings (20.2% per year) are forecast to grow slower than the BR market (27.3% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: GNDI3's revenue (15% per year) is forecast to grow faster than the BR market (10.4% per year).
High Growth Revenue: GNDI3's revenue (15% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: GNDI3's Return on Equity is forecast to be low in 3 years time (18.4%).
Next Steps
Past Performance
How has Notre Dame Intermédica Participações performed over the past 5 years?
41.2%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: GNDI3 has high quality earnings.
Growing Profit Margin: GNDI3's current net profit margins (6.9%) are higher than last year (5.3%).
Past Earnings Growth Analysis
Earnings Trend: GNDI3's earnings have grown significantly by 41.2% per year over the past 5 years.
Accelerating Growth: GNDI3's earnings growth over the past year (69.4%) exceeds its 5-year average (41.2% per year).
Earnings vs Industry: GNDI3 earnings growth over the past year (69.4%) exceeded the Healthcare industry -0.7%.
Return on Equity
High ROE: GNDI3's Return on Equity (10%) is considered low.
Next Steps
Financial Health
How is Notre Dame Intermédica Participações's financial position?
Financial Position Analysis
Short Term Liabilities: GNDI3's short term assets (R$4.8B) exceed its short term liabilities (R$3.1B).
Long Term Liabilities: GNDI3's short term assets (R$4.8B) do not cover its long term liabilities (R$5.7B).
Debt to Equity History and Analysis
Debt Level: GNDI3's debt to equity ratio (40%) is considered high.
Reducing Debt: GNDI3's debt to equity ratio has reduced from 64.9% to 40% over the past 5 years.
Debt Coverage: GNDI3's debt is well covered by operating cash flow (31.9%).
Interest Coverage: GNDI3's interest payments on its debt are well covered by EBIT (10.9x coverage).
Balance Sheet
Next Steps
Dividend
What is Notre Dame Intermédica Participações's current dividend yield, its reliability and sustainability?
0.63%
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate GNDI3's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate GNDI3's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if GNDI3's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if GNDI3's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of GNDI3's dividend in 3 years as they are not forecast to pay a notable one for the BR market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
4.0yrs
Average board tenure
CEO
Irlau Filho (54 yo)
no data
Tenure
Mr. Irlau Machado Filho serves as Independent Director at Localiza Rent a Car S.A. since 2020. He has been a Director of Notre Dame Intermédica Participações S.A. since 2017 and serves as its Chief Executi...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Member of Executive Board & Director | no data | no data | no data | |
| Independent Director | 2yrs | no data | no data | |
| President | no data | no data | no data | |
| Director | 4yrs | no data | no data | |
| Director | 4yrs | no data | no data | |
| Director | 4yrs | no data | no data | |
| Independent Director | 4yrs | no data | no data |
4.0yrs
Average Tenure
51yo
Average Age
Experienced Board: GNDI3's board of directors are considered experienced (4 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Notre Dame Intermédica Participações S.A.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Notre Dame Intermédica Participações S.A.
- Ticker: GNDI3
- Exchange: BOVESPA
- Founded: 1968
- Industry: Managed Health Care
- Sector: Healthcare
- Market Cap: R$59.784b
- Shares outstanding: 609.48m
- Website: https://www.gndi.com.br
Number of Employees
Location
- Notre Dame Intermédica Participações S.A.
- Avenida Paulista, nº 867
- Bela Vista
- São Paulo
- São Paulo
- 01311-100
- Brazil
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| GNDI3 | BOVESPA (Bolsa de Valores de Sao Paulo) | Yes | Common Shares | BR | BRL | Apr 2018 |
| NTED.Y | OTCPK (Pink Sheets LLC) | UNSPONSORED ADS | US | USD | Oct 2020 |
Biography
Notre Dame Intermédica Participações S.A. provides preventive medicine programs in Brazil. The company offers preventive medicine programs for pregnant women and the elderly, as well as the cases of patien...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/21 22:00 |
| End of Day Share Price | 2021/01/21 00:00 |
| Earnings | 2020/09/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.